Grown Rogue International Inc.

GRUSF

OTC

Healthcare

Drug Manufacturers - Specialty & Generic

Medford, OR, US204 employeesgrownrogue.com

—

AI-generated from 20-F FY2024 filed Apr 29, 2025

Grown Rogue International Inc., through its subsidiaries, engages in growing and selling cannabis products in the United States.

Revenue breakdown: Products (95.8%), Services (4.2%).

—Mkt Cap

—Rev TTM

—NI TTM

Latest Earnings

20-F

FY FY2024Apr 29, 2025

20-F for FY2024 was filed on 2025-04-30. AI summary is not available yet.

Read full analysis View SEC Filing

What Changed Recently

Regulation FDMar 30, 2026

, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabili

View filing →

Regulation FDFeb 17, 2026

. Regulation FD Disclosure. On February 18, 2026, Grown Rogue International Inc. (the “Company”) issued a press release announcing that it will report its finan

View filing →

View all recent events →

Fundamentals

How The Business Makes Money

Revenue by Segment

Products95.8%($69M)

Services4.2%($3M)

Peer Companies

Company	Price	Change	Market Cap	P/E
ORXOFOrexo AB (publ)	—	—	—	—
BIOYFBioSyent Inc.	—	—	—	—
IUGNFImugene Limited	—	—	—	—
ETSTEarth Science Tech, Inc.	—	—	—	—
HSCHFH-Source Holdings Ltd.	—	—	—	—
SHIEFShield Therapeutics plc	—	—	—	—
LOVFFCannara Biotech Inc.	—	—	—	—
MSCLFSatellos Bioscience Inc.	—	—	—	—

Company Profile

CIK0001463000

ISINCA39986R3045

CUSIP39986R106

Phone458 226 2100

Address550 Airport Road, Medford, OR, 97504, US

SEC EDGAR